查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493175

临床试验管理系统市场规模、份额、趋势分析报告：按解决方案类型、按交付模式、按组件、按最终用户、按地区、细分市场预测，2024-2030 年

Clinical Trials Management System Market Size, Share & Trends Analysis Report By Solution Type, By Delivery Mode (Web & Cloud-based, On-premise), By Component (Software, Services), By End-user, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

临床试验管理系统市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球临床试验管理系统市场规模将达到47.3亿美元，2024年至2030年复合年增长率为14.65%。

临床试验数量的增加、虚拟和分散临床试验的增加以及对电子临床解决方案的需求不断增长推动了市场成长。

生命科学公司研发投资的增加以及急性和慢性疾病的流行正在促进旨在改善患者治疗结果的临床试验的激增。例如，ClinicalTrials.gov 报告了 653 项正在进行的糖尿病临床试验，突显了对临床试验管理 (CTM) 系统等解决方案的高需求，以有效管理多个临床试验。

多位市场参与者正在针对 DCT 及其要求推出客製化解决方案或优化现有解决方案。例如，Cloudbyz的分散式CTM解决方案是云端基础的CTM解决方案，提供ePRO、远端监控和SDV、eConsent、eCRF、EDC、eCOA、eDiary、虚拟PR、eTMF等多种功能来支援虚拟考试。截至 2022 年，市场主要参与者 Parexel International Corporation 已进行了 250 多次完全虚拟或混合DCT，并实施了 200 多项远距病人参与策略（例如病患招募、电子就诊、保留平台）。的记录。

临床试验管理系统市场报告亮点

  • 该市场的推动因素包括医疗保健 IT 的快速成长、临床试验数量的增加、CTMS 解决方案的日益采用以及已开发国家和新兴国家政府对临床研究的支持。
  • 按解决方案类型划分，企业细分市场在 2023 年以 74.35% 的最大收入份额引领市场。主要优势包括提供偏差和应计费用的端到端洞察、强大的彙报、解决方案的扩充性、追踪和管理监管流程以及增强的申请合规性。
  • 按组成部分来看，软体领域在 2023 年以 56.04% 的最大收入份额引领市场。这是因为它是一个易于使用的工具，可以帮助您管理临床试验并执行关键功能。
  • 按交付格式划分，网路和云端领域以 2023 年 56.04% 的最大销售份额引领市场。
  • 按最终用途划分，由于合作的增加、临床试验外包给CRO以及临床试验数量的多样化，CRO和其他细分市场在2023年占据了最大的收益占有率，为40.16%。
  • 北美在2023年以50.01%的收益占有率主导市场，这得益于技术进步、该地区市场参与者的强大存在、临床试验领域的技术进步以及政府对促进临床试验的政策支持。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章临床试验管理系统市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 临床试验管理系统市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章临床试验管理系统市场：解决方案类型估算及趋势分析

  • 2023 年和 2030 年解决方案类型市场占有率
  • 细分仪表板
  • 按解决方案类型分類的全球临床试验管理系统市场前景
  • 说明分析
  • 公司
  • 地点

第五章临床试验管理系统市场：成分估计与趋势分析

  • 2023 年及 2030 年零件市场占有率
  • 细分仪表板
  • 全球临床试验管理系统市场，按组成部分的前景
  • 软体
  • 服务

第六章 临床试验管理系统市场：提供模式预估及趋势分析

  • 2023 年和 2030 年交付模式市场占有率
  • 细分仪表板
  • 按交付模式分類的全球临床试验管理系统市场前景
  • 本地
  • 云端基础的

第七章临床试验管理系统市场：最终使用者估计与趋势分析

  • 2023年及2030年应用市场占有率
  • 细分仪表板
  • 全球临床试验管理系统市场应用前景展望
  • 製药和生物技术公司
  • 医疗设备公司
  • CRO及其他

第八章临床试验管理系统市场：区域估计和趋势分析，按解决方案类型、按组件、按交付模式、按最终用途

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 主要客户
    • 2023年主要企业市场占有率分析
    • IQVIA, Inc.
    • Medidata（Dassault Systemes）
    • Oracle
    • DATATRAK International, Inc.
    • Clario
    • SimpleTrials
    • Calyx（formerly Parexel Informatics）
    • RealTime Software Solutions, LLC
    • Laboratory Corporation of America Holdings
    • Veeva Systems
    • Wipro Limited
    • PHARMASEAL International Ltd
Product Code: GVR-1-68038-150-4

Clinical Trials Management System Market Growth & Trends:

The global clinical trials management system market size is anticipated to reach USD 4.73 billion by 2030 and is projected to grow at a CAGR of 14.65% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing number of clinical trials, a rise in virtual or decentralized clinical trials, and the growing demand for eClinical solutions are some of the factors contributing to the market growth.

Life science companies' rising R&D investments and the prevalence of acute and chronic disorders contribute to the surge in clinical trials aimed at enhancing patient outcomes. For instance, ClinicalTrials.gov reports 653 active clinical trials on diabetes, indicating a significant demand for solutions like Clinical Trial Management (CTM) systems to efficiently manage multiple trials.

Several market players are launching tailored solutions or optimizing existing solutions to fit DCTs and their requirements. For example, the decentralized CTM Solution by Cloudbyz offers a cloud-based CTM solution that offers a range of features such as ePRO, remote monitoring & SDV, eConsent, eCRF, EDC, eCOA, eDiary, virtual PR, and eTMF to support virtual trials. As of 2022, Parexel International Corporation, a key player in the market, conducted over 250 fully virtual or hybrid DCTs and has experience with over 200 remote patient engagement strategies, e.g., patient recruitment, e-visits, and retention platforms, incorporated into trials.

Clinical Trials Management System Market Report Highlights:

  • The market is primarily driven by rapid growth of healthcare IT, rise in the number of clinical trials, increased adoption of CTMS solutions, and government support for clinical research in both developed & developing countries
  • Based on solution type, the enterprise segment led the market with the largest revenue share of 74.35% in 2023, owing to its key benefits, such as offering end-to-end insights into deviations & accruals, robust reporting, scalability of solutions, tracking & managing regulatory processes, and enhanced billing compliance
  • Based on component, the software segment led the market with the largest revenue share of 56.04% in 2023, due to it being an easy-to-use tool that helps manage clinical trials and perform critical functions
  • Based on delivery mode, web & cloud segment led the market with the largest revenue share of 56.04% in 2023, due to its increased adoption by end users
  • Based on end user, the CRO and others segment held the market with the largest revenue share of 40.16% in 2023, owing to the increasing number of partnerships, clinical trial outsourcing to CROs, and decentralized trial counts
  • North America dominated the market with a revenue share of 50.01% in 2023, owing to the technological advancements, strong presence of market players in the regions, technological advancement in the field of clinical trials, and supportive government policies to promote clinical trials

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Solution Type
    • 1.1.2. Component
    • 1.1.3. Delivery mode
    • 1.1.4. End user
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Solution type outlook
    • 2.2.2. Component outlook
    • 2.2.3. Delivery mode outlook
    • 2.2.4. End user outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trials Management System Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Clinical Trials Management System Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Clinical Trials Management System Market: Solution Type Estimates & Trend Analysis

  • 4.1. Solution Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Clinical Trials Management System Market, by Solution Type Outlook
  • 4.4. Descriptive Analysis
    • 4.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 4.5. Enterprise
    • 4.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 4.6. Site
    • 4.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trials Management System Market: Component Estimates & Trend Analysis

  • 5.1. Component Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Clinical Trials Management System Market, by Component Outlook
  • 5.4. Software
    • 5.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 5.5. Services
    • 5.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trials Management System Market: Delivery Mode Estimates & Trend Analysis

  • 6.1. Delivery Modes Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Clinical Trials Management System Market, by Delivery Modes Outlook
  • 6.4. On-Premises
    • 6.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 6.5. Web & Cloud-Based
    • 6.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 7. Clinical Trials Management System Market: End-user Estimates & Trend Analysis

  • 7.1. Application Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Clinical Trials Management System Market by Application Outlook
  • 7.4. Pharmaceutical and Biotechnology Firms
    • 7.4.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 7.5. Medical Device Firms
    • 7.5.1. Market estimates and forecast, 2018 to 2030 (USD Million)
  • 7.6. CROs & Others
    • 7.6.1. Market estimates and forecast, 2018 to 2030 (USD Million)

Chapter 8. Clinical Trials Management System Market: Regional Estimates & Trend Analysis, By Solution Type, By Component, By Delivery Mode, By End Use

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework/ reimbursement structure
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework/ reimbursement structure
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework/ reimbursement structure
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.6. Denmark
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework/ reimbursement structure
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework/ reimbursement structure
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.6.8. Norway
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework/ reimbursement structure
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework/ reimbursement structure
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework/ reimbursement structure
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework/ reimbursement structure
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.8.2. Mexico
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework/ reimbursement structure
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.8.3. Argentina
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Regulatory framework/ reimbursement structure
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework/ reimbursement structure
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework/ reimbursement structure
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework/ reimbursement structure
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework/ reimbursement structure
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Innovators
  • 9.3. Vendor Landscape
    • 9.3.1. List of key distributors and channel partners
    • 9.3.2. Key customers
    • 9.3.3. Key company market share analysis, 2023
    • 9.3.4. IQVIA, Inc.
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Medidata (Dassault Systemes)
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Oracle
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. DATATRAK International, Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Clario
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. SimpleTrials
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Calyx (formerly Parexel Informatics)
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. RealTime Software Solutions, LLC
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Laboratory Corporation of America Holdings
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. Veeva Systems
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
    • 9.3.14. Wipro Limited
      • 9.3.14.1. Company overview
      • 9.3.14.2. Financial performance
      • 9.3.14.3. Product benchmarking
      • 9.3.14.4. Strategic initiatives
    • 9.3.15. PHARMASEAL International Ltd
      • 9.3.15.1. Company overview
      • 9.3.15.2. Financial performance
      • 9.3.15.3. Product benchmarking
      • 9.3.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America clinical trials management system market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 4 North America clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 5 North America clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 6 North America clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 7 U.S. clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 8 U.S. clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 9 U.S. clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 10 U.S. clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 12 Canada clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 13 Canada clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 14 Canada clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe clinical trials management system market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 17 Europe clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 18 Europe clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 19 Europe clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Germany clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 21 Germany clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 22 Germany clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 23 Germany clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 24 U.K. clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 25 U.K. clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 26 U.K. clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 27 U.K. clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 28 France clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 29 France clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 30 France clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 31 France clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 33 Italy clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 34 Italy clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 35 Italy clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 37 Spain clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 38 Spain clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 39 Spain clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Denmark clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 41 Denmark clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 42 Denmark clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 43 Denmark clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Sweden clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 45 Sweden clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 46 Sweden clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 47 Sweden clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Norway clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 49 Norway clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 50 Norway clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 51 Norway clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific clinical trials management system market, by region, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 57 China clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 58 China clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 59 China clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 60 China clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Japan clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 62 Japan clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 63 Japan clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 64 Japan clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 65 India clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 66 India clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 67 India clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 68 India clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 69 South Korea clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 70 South Korea clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 71 South Korea clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 72 South Korea clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Australia clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 74 Australia clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 75 Australia clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 76 Australia clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 77 Thailand clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 78 Thailand clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 79 Thailand clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 80 Thailand clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Latin America clinical trials management system market, by region, 2018 - 2030 (USD Million)
  • Table 82 Latin America clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 83 Latin America clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 84 Latin America clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 85 Latin America clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Brazil clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 87 Brazil clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 88 Brazil clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 89 Brazil clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Mexico clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 91 Mexico clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 92 Mexico clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 93 Mexico clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 95 Argentina clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 96 Argentina clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 97 Argentina clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 98 MEA clinical trials management system market, by region, 2018 - 2030 (USD Million)
  • Table 99 MEA clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 100 MEA clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 101 MEA clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 102 MEA clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 103 South Africa clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 104 South Africa clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 105 South Africa clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 106 South Africa clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 112 UAE clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 113 UAE clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 114 UAE clinical trials management system market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait clinical trials management system market, by solution type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait clinical trials management system market, by component, 2018 - 2030 (USD Million)
  • Table 117 Kuwait clinical trials management system market, by delivery mode, 2018 - 2030 (USD Million)
  • Table 118 Kuwait clinical trials management system market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical trials management system market: market outlook
  • Fig. 9 Clinical trials management system competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Clinical trials management system market driver impact
  • Fig. 15 Clinical trials management system market restraint impact
  • Fig. 16 Clinical trials management system market strategic initiatives analysis
  • Fig. 17 Clinical trials management system market: Solution type movement analysis
  • Fig. 18 Clinical trials management system market: Solution type outlook and key takeaways
  • Fig. 19 Descriptive analysis market estimates and forecast, 2018 - 2030
  • Fig. 20 Enterprise market estimates and forecast, 2018 - 2030
  • Fig. 21 Site market estimates and forecast, 2018 - 2030
  • Fig. 22 Clinical trials management system market: Component movement analysis
  • Fig. 23 Clinical trials management system market: Component outlook and key takeaways
  • Fig. 24 Software market estimates and forecast, 2018 - 2030
  • Fig. 25 Services market estimates and forecast, 2018 - 2030
  • Fig. 26 Clinical trials management system market: Delivery mode movement analysis
  • Fig. 27 Clinical trials management system market: Delivery mode outlook and key takeaways
  • Fig. 28 On-premise systems market estimates and forecast, 2018 - 2030
  • Fig. 29 Web & cloud-based systems market estimates and forecast, 2018 - 2030
  • Fig. 30 Clinical trials management system market: End user movement analysis
  • Fig. 31 Clinical trials management system market: End user outlook and key takeaways
  • Fig. 32 Pharmaceutical and biotechnology firms market estimates and forecast, 2018 - 2030
  • Fig. 33 Medical device firms market estimates and forecast, 2018 - 2030
  • Fig. 34 CROs & others market estimates and forecast, 2018 - 2030
  • Fig. 35 Global clinical trials management system market: Regional movement analysis
  • Fig. 36 Global clinical trials management system market: Regional outlook and key takeaways
  • Fig. 37 Global clinical trials management system market share and leading players
  • Fig. 38 North America market share and leading players
  • Fig. 39 Europe market share and leading players
  • Fig. 40 Asia Pacific market share and leading players
  • Fig. 41 Latin America market share and leading players
  • Fig. 42 Middle East & Africa market share and leading players
  • Fig. 43 North America: SWOT
  • Fig. 44 Europe SWOT
  • Fig. 45 Asia Pacific SWOT
  • Fig. 46 Latin America SWOT
  • Fig. 47 MEA SWOT
  • Fig. 48 North America
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030
  • Fig. 50 US
  • Fig. 51 US market estimates and forecasts, 2018 - 2030
  • Fig. 52 Canada
  • Fig. 53 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 54 Europe
  • Fig. 55 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 56 UK
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany
  • Fig. 59 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 60 France
  • Fig. 61 France market estimates and forecasts, 2018 - 2030
  • Fig. 62 Italy
  • Fig. 63 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 64 Spain
  • Fig. 65 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 66 Denmark
  • Fig. 67 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 68 Sweden
  • Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 70 Norway
  • Fig. 71 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 72 Asia Pacific
  • Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 74 China
  • Fig. 75 China market estimates and forecasts, 2018 - 2030
  • Fig. 76 Japan
  • Fig. 77 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 78 India
  • Fig. 79 India market estimates and forecasts, 2018 - 2030
  • Fig. 80 Thailand
  • Fig. 81 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 82 South Korea
  • Fig. 83 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 86 Latin America
  • Fig. 87 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 88 Brazil
  • Fig. 89 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 90 Mexico
  • Fig. 91 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 92 Argentina
  • Fig. 93 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 94 Middle East and Africa
  • Fig. 95 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 96 South Africa
  • Fig. 97 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 98 Saudi Arabia
  • Fig. 99 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 100 UAE
  • Fig. 101 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 102 Kuwait
  • Fig. 103 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 104 Market share of key market players- Clinical trials management system market